Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CareStream

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 November 1997:
Vol. 278. no. 5343, p. 1541
DOI: 10.1126/science.278.5343.1541i

This Week in Science

An unusual subset of T cells, natural killer T (NKT) cells, all have the same T cell receptor and all bear some NK cell markers; two reports show that they play a role in fighting tumors. Cui et al. (p. 1623) now show that these cells seem to be indispensable for the control of syngenic tumors mediated by interleukin-12. The mechanism involves the production of interferon gamma by these cells. Kawano et al. (p. 1626) found that NKT cells recognize a galactosylceramide lipid found in marine sponges in the context of CD1d; an analog of this lipid may be the natural ligand for antigen recognition. Addition of galactosylceramide in a model of tumor metastasis activated these cells and inhibited development of tumor metastases. Activation of the NKT cells is similar to T cells, but their effector function is more like NK cells.





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)